No black box warning on record for Macrilen

As of the latest FDA labeling reviewed, Macrilen (MACIMORELIN ACETATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Macrilen medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • QT Prolongation: QT prolongation can lead to development of torsade de pointes-type ventricular tachycardia. Avoid the concomitant use of MACRILEN with drugs that are known to prolong QT interval ( 5.1 , 7.1 ). • Potential for False Positive Test Results with Use of Strong CYP3A4 Inducers: Discontinue and washout strong CYP3A4 inducers before testing ( 5.2 , 7.2 ). • P

No black box warning on record for Macrilen

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • QT Prolongation: QT prolongation can lead to development of torsade de pointes-type ventricular tachycardia. Avoid the concomitant use of MACRILEN with drugs that are known to prolong QT interval ( 5.1 , 7.1 ). • Potential for False Positive Test Results with Use of Strong CYP3A4 Inducers: Discontinue and washout strong CYP3A4 inducers before testing ( 5.2 , 7.2 ). • P

Macrilen Black Box Warning

No black box warning on record for Macrilen

Other warnings & precautions

Macrilen Black Box Warning

No black box warning on record for Macrilen

Other warnings & precautions